NumFin

ZhuZhou QianJin Pharmaceutical Co.,Ltd

Sümbol: 600479.SS

SHH

10.91

CNY

Turuhind täna

  • 17.9517

    P/E suhe

  • 0.4616

    PEG suhe

  • 4.56B

    MRK Cap

  • 0.03%

    DIV tootlus

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes ZhuZhou QianJin Pharmaceutical Co.,Ltd fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

01997.91731.71369.7
1407.6
1378
1100.2
690.3
736.2
544.3
297
205.3
243.2
217.7
334.9
416.9
507.4
527.4
435.8
410.4
383.6
71.3
72.9
93.4

balance-sheet.row.short-term-investments

0-45.7491.7736.8
652.3
-39.6
109.1
182.2
7.8
31.1
69.6
22.1
92.5
98.5
60.3
232
0.2
130
35
6
6.1
0
0
0.2

balance-sheet.row.net-receivables

0967983.9921.6
1164.8
1078.8
972.4
1043
951.2
843.5
876.3
743
610.6
558.1
307.8
260.4
196.8
105.9
113.7
143.4
160.4
113.9
82.8
97.7

balance-sheet.row.inventory

0534.1599547.8
496.8
469.5
440.9
376.3
358.5
272.3
243.2
222.5
195.3
117
126.5
98.8
96.5
82.9
87.3
75.1
84.1
84.9
71
77.5

balance-sheet.row.other-current-assets

015.4198.978.1
120.2
29
82.9
319.7
87.2
267.7
27
5.6
6.7
-29.7
-12.6
-9.8
-12.1
-4.2
-7.1
-8.7
-13.2
-11.6
-13.5
-19.4

balance-sheet.row.total-current-assets

03514.53513.52917.3
3189.3
2955.3
2596.3
2429.2
2133
1927.8
1443.6
1176.4
1055.8
863.1
756.5
766.3
788.6
711.9
629.7
620.1
614.8
258.5
213.1
249.1

balance-sheet.row.property-plant-equipment-net

0589.9622.8630.2
491
478.7
499.8
529.2
565.4
491.4
415.2
396.8
334.6
309.8
285.4
286.7
193.2
153.4
154.6
160
163
150.2
134.7
77.3

balance-sheet.row.goodwill

014.114.114.1
14.1
14.1
14.1
14.1
14.1
14.1
14.1
14.1
8.7
8.7
8.7
8.7
8.7
8.7
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0238.3221.8219.6
216.4
255.2
285.8
241.2
259.8
260.4
247.3
252.8
199.5
45.3
46.5
47.7
47.1
20.2
20.2
4.4
4.6
4.6
4.5
4.6

balance-sheet.row.goodwill-and-intangible-assets

0252.3235.9233.7
230.5
269.3
299.9
255.3
273.9
274.5
261.4
266.9
208.2
54
55.2
56.5
55.8
28.9
20.2
4.4
4.6
4.6
4.5
4.6

balance-sheet.row.long-term-investments

0293.3-304.1-546.1
-462
103
-63.7
-136.8
37.6
4.3
-33.2
14.2
-57.2
-57
-40.5
-86.9
13.4
54
-16.4
3.9
0.5
0
0
0.4

balance-sheet.row.tax-assets

022.76.64.1
4.2
4.2
4.6
6.9
4
3.4
2.5
2.7
1.3
2.1
0.9
0.5
0.5
1.4
0
0
0
0
0
1.3

balance-sheet.row.other-non-current-assets

04.2547.3821
775.7
1.7
135.7
203
18.2
41.9
139.5
31.2
102.4
109.7
71
242.8
7.9
135.6
40.7
9.8
9.7
7.9
7.6
0

balance-sheet.row.total-non-current-assets

01162.41108.51143
1039.4
856.9
876.2
857.6
899.1
815.4
785.4
711.9
589.4
418.6
371.9
499.5
270.8
373.3
199
178.1
177.7
162.8
146.8
83.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

04676.946224060.2
4228.7
3812.2
3472.5
3286.9
3032.1
2743.2
2228.9
1888.3
1645.2
1281.7
1128.5
1265.8
1059.4
1085.3
828.7
798.2
792.5
421.3
359.9
332.8

balance-sheet.row.account-payables

0647.5780.9511.7
623
529.1
485.8
469.5
446
317
369.4
168.9
86.1
80.2
80.7
109
91.7
82
81
56.1
69.5
74.6
49.1
77.3

balance-sheet.row.short-term-debt

078.279.588.6
135.9
1.9
1
1
0.5
3.1
61
87
115.9
0
0
131
0
0
0
0
12
33.1
32.8
1.5

balance-sheet.row.tax-payables

070.672.535.6
45.2
41
61.3
67.5
32.9
23.1
41.6
28.4
28.4
34.3
10
15.2
26.6
23.7
23.2
11.3
11.6
18.9
17.1
12.9

balance-sheet.row.long-term-debt-total

038.544.860.3
19.5
20.5
26.7
37.3
47.3
54
32
5.2
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
8.7

Deferred Revenue Non Current

03844.451.3
51.8
42.8
44.4
51.5
50.2
52.9
41.6
44.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

069.1705.675.5
84.9
192.3
407.8
130.1
165.4
149.6
125
97.9
76.8
181.3
81.5
19.5
89.4
83.6
85.5
144.7
1.9
5.5
1.6
0.7

balance-sheet.row.total-non-current-liabilities

0108.3108.5131.9
89
81.5
86.6
111.3
111.2
117.6
84.3
55.3
30
26.6
26.5
2.6
2.6
23.7
2.6
2.6
3
3.4
3.4
11.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

031.532.844.8
42.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

01650.11805.71360.3
1466.7
1182.6
1042.5
1045.7
948.2
779.2
843.2
683.9
581.2
288.1
188.6
314.5
183.7
189.3
169.1
203.4
148.4
188.2
174.3
182.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0428.9429.8418.5
418.5
418.5
418.5
348.8
348.8
348.8
304.8
304.8
304.8
304.8
304.8
217.7
181.4
151.2
126
84
56
38
38
38

balance-sheet.row.retained-earnings

01142.5970.8930.7
1047.2
959.4
826.1
694.2
568.4
481.4
456.1
414.1
377.7
328.3
328.2
356.9
295.8
260.5
115.5
60.7
122.1
114.1
71.9
57.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

0280.8275.3298.1
298.1
297.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0537.5540.3503
503
503
784.2
834.4
828.5
816.7
360.6
289.3
283.5
275.2
268.6
349.4
374.2
463
399
433.8
452.5
64.8
56
40.1

balance-sheet.row.total-stockholders-equity

02389.72216.22150.4
2266.8
2178.1
2028.8
1877.4
1745.7
1646.8
1121.5
1008.2
966
908.3
901.6
924
851.4
874.6
640.6
578.5
630.6
216.9
165.8
135.4

balance-sheet.row.total-liabilities-and-stockholders-equity

04676.946224060.2
4228.7
3812.2
3472.5
3286.9
3032.1
2743.2
2228.9
1888.3
1645.2
1281.7
1128.5
1265.8
1059.4
1085.3
828.7
798.2
792.5
421.3
359.9
332.8

balance-sheet.row.minority-interest

0637.1600.1549.5
495.2
451.5
401.1
363.8
338.2
317.2
264.3
196.2
98
85.3
38.2
27.3
24.3
21.3
19
16.4
13.5
16.1
19.7
14.5

balance-sheet.row.total-equity

03026.82816.32699.9
2762
2629.6
2430
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0247.6187.6190.8
190.3
63.4
45.3
45.3
45.3
35.3
36.3
36.3
35.3
41.6
19.8
145.1
13.6
184
18.6
10
6.5
6.5
5.5
0.5

balance-sheet.row.total-debt

0116.7124.2148.9
155.4
22.4
27.7
38.3
47.8
57.1
93
87
115.9
0.7
0.7
131
0.7
0.7
0.7
0.7
12
33.1
32.8
1.5

balance-sheet.row.net-debt

0-1881.2-1115.7-484
-600
-1355.5
-963.4
-469.8
-680.6
-456.1
-134.4
-96.2
-34.8
-118.5
-274
-53.9
-506.6
-396.7
-400.1
-403.7
-365.5
-38.2
-40.1
-91.7

Rahavoogude aruanne

ZhuZhou QianJin Pharmaceutical Co.,Ltd finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002

cash-flows.row.net-income

0395388.3374.7
360.2
352.1
302.6
246.7
173.4
88.3
117.7
128.8
130.9
94.8
97.6
136.9
134.5
176.6
75
61.7
46.6
48.4
38.9

cash-flows.row.depreciation-and-amortization

0103.795.685.9
60.9
61.1
61.8
62.7
50.2
50.4
48.5
48.3
40
38.3
36
25.2
21.8
20.9
24.3
23.3
22
18.3
13.1

cash-flows.row.deferred-income-tax

0-2.8-3.62.7
1.4
-0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

02.83.6-2.7
-1.4
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-81.7246.965.8
129.5
-233
29.3
-11.8
-81.8
-73.8
15.1
-49.5
40.4
-122.7
-81.4
-68.9
-88.6
2.4
47.2
-1.1
-46.4
-19.4
-45.6

cash-flows.row.account-receivables

0-8.7-163.7275.9
27.2
-362.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

062.3-51.2-52.4
-27.3
-29.1
-64.7
-17.9
-85.5
-29.9
-22.4
-19.8
-78.4
9.6
-27.7
-2
-13.2
3.7
1.7
8.3
1
-13.8
3.1

cash-flows.row.account-payables

0-132.5465.4-160.4
128.2
159.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-2.8-3.62.7
1.4
-0.9
94
6.1
3.8
-44
37.4
-29.6
118.8
-132.3
-53.7
-66.8
-75.4
-1.3
45.5
-9.4
-47.4
-5.6
-48.7

cash-flows.row.other-non-cash-items

026.12.7-40.9
-8.2
-24.7
-10.2
-14.1
-0.9
2.6
2.1
10.1
-13.6
12.2
-13
-19.7
-30.4
-120.6
-26.3
-7.5
-3.8
3.6
-0.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-44-34.4-71.9
-97.2
-40.6
-46.4
-57.3
-81.5
-84.5
-66
-84.3
-256.3
-63.9
-58.4
-123.3
-95.3
-22.5
-21.4
-16.7
-56.5
-34
-59.2

cash-flows.row.acquisitions-net

000.230.8
103.6
73
0
13
0.7
85
1.2
-21.4
0.6
1.3
5.8
0.8
0.3
0.8
2.1
0.6
1
0.1
0.2

cash-flows.row.purchases-of-investments

0-402-2102-1570
-2641
-285
-904
-1403.9
-1001.7
-769.6
-405
-135.1
-235.4
-891.1
-565.5
-1545.8
-1482
-576.3
-855.2
-1103.4
-225.3
-1
-5

cash-flows.row.sales-maturities-of-investments

01031.22258.41567.7
1770.3
469.5
1222.9
1006.1
1197.1
605.1
357.6
207.4
266.3
820.6
889.9
1194
1728.4
549.6
845.8
1107.5
219.4
0.5
0.3

cash-flows.row.other-investing-activites

00.100
-97.2
-40.6
2.5
24.3
5.9
-84.5
0.4
0.1
0
-3.9
1.6
2.8
2.8
3.1
2.4
1.8
3.7
2
1.6

cash-flows.row.net-cash-used-for-investing-activites

0585.3122.1-43.3
-961.5
176.3
275
-417.8
120.6
-248.5
-111.8
-33.3
-224.7
-137
273.3
-471.5
154.1
-45.3
-26.3
-10.3
-57.8
-32.5
-62.2

cash-flows.row.debt-repayment

0-50.7-15-127.6
-19.1
-6.2
-10.6
-9.5
-9.3
-105
-147
-180.9
-7.5
-20
-605
-4937
0
-550
-700
-12
-333.7
-39.7
-15.3

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-147.9-248.6-429.5
-209.3
-167.1
-105
-71.4
-54.4
-66.7
-60.7
-79.9
-61.3
-76.2
-108.9
-59.5
-79.6
-36.4
-96
-28.2
-32.1
-22
-7.7

cash-flows.row.other-financing-activites

0-13.1-0.536.5
124.2
-7.4
-9.1
-12.7
-1.2
620
154.9
180.8
125
55.2
497.8
5065.6
-1.9
548.9
698.6
0.9
711.3
41.7
58.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0-202-264.2-520.6
-104.2
-180.7
-124.7
-93.6
-65
448.4
-52.8
-80
56.2
-41.1
-216.1
69.1
-81.5
-37.4
-97.3
-39.3
345.5
-20
35.8

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0826.4591.4-78.3
-523.4
151.1
533.7
-227.9
196.4
267.4
18.8
24.3
29.3
-155.4
96.3
-328.9
109.9
-3.4
-3.6
26.9
306.2
-1.5
-20.3

cash-flows.row.cash-at-end-of-period

01928.31101.9510.5
588.8
1112.3
961.2
427.4
655.4
458.9
191.5
172.8
148.5
119.2
274.6
178.4
507.2
397.4
400.8
404.3
377.5
71.3
72.9

cash-flows.row.cash-at-beginning-of-period

01101.9510.5588.8
1112.3
961.2
427.4
655.4
458.9
191.5
172.8
148.5
119.2
274.6
178.4
507.2
397.4
400.8
404.3
377.5
71.3
72.9
93.2

cash-flows.row.operating-cash-flow

0443.1733.5485.6
542.4
155.5
383.5
283.5
140.9
67.5
183.3
137.6
197.8
22.6
39.1
73.5
37.2
79.3
120.1
76.5
18.5
51
6.1

cash-flows.row.capital-expenditure

0-44-34.4-71.9
-97.2
-40.6
-46.4
-57.3
-81.5
-84.5
-66
-84.3
-256.3
-63.9
-58.4
-123.3
-95.3
-22.5
-21.4
-16.7
-56.5
-34
-59.2

cash-flows.row.free-cash-flow

0399.1699413.7
445.1
114.9
337.1
226.2
59.4
-17
117.4
53.4
-58.4
-41.3
-19.3
-49.8
-58.1
56.7
98.7
59.8
-38
16.9
-53.2

Kasumiaruande rida

ZhuZhou QianJin Pharmaceutical Co.,Ltd tulud muutusid võrreldes eelmise perioodiga NaN%. 600479.SS brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

03798.54026.33663.8
3627
3525.2
3328.6
3182.7
2864.9
2446.7
2194.2
1972.9
1583.4
1256.5
979.4
904.3
801.4
679.8
602.7
665.8
604.9
686.8
582
560.2

income-statement-row.row.cost-of-revenue

02046.72289.92032.2
2030.8
1918.7
1776.3
1743.2
1573.3
1311.5
1141.1
1006.8
786.3
603.5
427.9
360.8
345.8
322.3
309.4
423.8
409.4
476.1
405.9
417.3

income-statement-row.row.gross-profit

01751.81736.41631.6
1596.2
1606.5
1552.3
1439.5
1291.6
1135.2
1053.1
966
797.1
653
551.6
543.4
455.6
357.5
293.3
242
195.5
210.7
176.1
142.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-3337.9218.6189.1
156.1
147.8
14.9
-9.7
13.6
15
10.5
3.7
0.7
1.6
8.1
1.7
-1.1
0.1
1.2
1.3
1.8
-0.8
-0.9
-2

income-statement-row.row.operating-expenses

03337.91311.71261.1
1224.8
1247.8
1249.1
1170.9
1111.7
1042.9
924.3
810.4
663.7
536.5
474
404.5
345.3
282.9
237.7
178
146.3
142.3
118.1
92.9

income-statement-row.row.cost-and-expenses

03337.93601.53293.4
3255.6
3166.5
3025.4
2914.1
2685
2354.4
2065.4
1817.2
1450
1140.1
901.8
765.3
691
605.2
547.1
601.8
555.7
618.4
524
510.1

income-statement-row.row.interest-income

051.49.811.9
30.4
38.6
20.9
11.7
10.9
4.6
1.2
0.2
1.7
4.1
1.6
0
0
0
2.4
1.8
3.7
1.9
1.6
1.7

income-statement-row.row.interest-expense

01.72.22.1
2.2
0.4
0.7
2.6
2.8
6.5
6.1
4.1
2.1
0.2
0.1
-1
-1.9
0.7
1.1
0.1
1.2
2.3
1.1
0.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1.51.6-2.8
0.4
-1.1
49.1
18
26.5
17.3
11.6
-2.8
17.9
-6.8
31.9
17.1
31.4
123.3
27.9
9.1
6.5
1.2
1.3
-0.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-3337.9218.6189.1
156.1
147.8
14.9
-9.7
13.6
15
10.5
3.7
0.7
1.6
8.1
1.7
-1.1
0.1
1.2
1.3
1.8
-0.8
-0.9
-2

income-statement-row.row.total-operating-expenses

0-1.51.6-2.8
0.4
-1.1
49.1
18
26.5
17.3
11.6
-2.8
17.9
-6.8
31.9
17.1
31.4
123.3
27.9
9.1
6.5
1.2
1.3
-0.5

income-statement-row.row.interest-expense

01.72.22.1
2.2
0.4
0.7
2.6
2.8
6.5
6.1
4.1
2.1
0.2
0.1
-1
-1.9
0.7
1.1
0.1
1.2
2.3
1.1
0.3

income-statement-row.row.depreciation-and-amortization

0103.7104.247.3
60.3
40.8
61.8
62.7
50.2
50.4
48.5
48.3
40
38.3
36
25.2
21.8
20.9
24.3
23.3
22
18.3
13.1
-1.9

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0460.6444.2436.2
424.2
430.8
337.4
296.3
194
94.8
130.4
150
150.9
108.1
101.5
155.2
143.1
198.9
83.9
74.3
55.3
71.5
60.2
51.9

income-statement-row.row.income-before-tax

0459.1445.8433.4
424.6
429.7
352.3
286.6
206.4
109.6
140.4
152.8
151.3
109.7
109.5
156.1
141.8
197.9
84.3
74.3
56.4
70.1
59.3
49.7

income-statement-row.row.income-tax-expense

065.457.658.7
64.4
77.6
49.7
40
33
21.3
22.7
24.1
20.4
14.9
12
19.1
7.3
21.3
9.4
12.6
9.8
21.7
20.3
14.4

income-statement-row.row.net-income

0320.4302.5302.1
297.1
294.3
255.4
207.8
149.4
93
105.1
123.8
120.2
82.8
86.4
130.9
129.9
173.6
71.8
59.9
45.4
50.1
39.8
34.5
Sarnased aktsiad
Sind võib huvitada ka:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Korduma kippuv küsimus

Mis on ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) koguvara?

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) koguvara on 4676882466.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.465.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 1.021.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.073.

Mis on ettevõtte kogutulu?

Kogutulu on 0.121.

Mis on ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 320405834.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 116705915.000.

Mis on tegevuskulude arv?

Tegevuskulud on 3337921320.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.